glp 1 agonist diarrhea semaglutide Semaglutide is a FDA-approved GLP-1 receptor used to improve blood sugar Clinical Recommendations to Manage Gastrointestinal
Description
10.1093/brain/awaa262 [DOI] [PMC free article] [PubMed] [Google Scholar] 77.Hankey GJ, Blacker DJ
This is a significant concern for businesses who might be adversely affected by lower volumes of food sales to obese individuals
Urva, T
Moon, S
Outcomes of a family based pediatric obesity programpreliminary results
In 2024 the Food and Drug Administration added cardiovascular risk as a reason to be prescribed the GLP-1 drug Wegovy, grounded in results from a major trial that showed fewer heart attacks, strokes, and cardiovascular deaths in adults with obesity or overweight and established heart disease
